comparemela.com

Latest Breaking News On - Alzamend neuro inc - Page 1 : comparemela.com

Critical Survey: Alzamend Neuro (NASDAQ:ALZN) and Structure Therapeutics (NASDAQ:GPCR)

Alzamend Neuro (NASDAQ:ALZN – Get Free Report) and Structure Therapeutics (NASDAQ:GPCR – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, valuation, profitability, analyst recommendations, earnings, institutional ownership and dividends. Valuation and Earnings This table compares Alzamend […]

Alzamend Neuro, Inc (NASDAQ:ALZN) Short Interest Up 55 2% in April

Alzamend Neuro, Inc (NASDAQ:ALZN) Short Interest Up 55 2% in April
defenseworld.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from defenseworld.net Daily Mail and Mail on Sunday newspapers.

Alzamend Neuro Announces Agreement for Registered Direct Offering and Concurrent Private Placement for an Aggregate of up to $25 Million

Alzamend Neuro Announces Agreement for Registered Direct Offering and Concurrent Private Placement for an Aggregate of up to $25 Million
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Alzamend Neuro To Raise Up To $25M Via Private Placement Of Preferred Shares

Alzamend Neuro To Raise Up To $25M Via Private Placement Of Preferred Shares
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.

Alzamend Neuro Announces Termination of At-the-Market Equity Offering Program

Alzamend Neuro Announces Termination of At-the-Market Equity Offering Program
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.